Contact
Please use this form to send email to PR contact of this press release:
Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates
TO:
Please use this form to send email to PR contact of this press release:
Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates
TO: